|
|
|
Volumn 36, Issue 9, 2001, Pages 1468-1469
|
|
Correspondence [3] (multiple letters)
a
a
NONE
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
GDNF PROTEIN, HUMAN;
NERVE GROWTH FACTOR;
NERVE PROTEIN;
CELL MATURATION;
GLIA CELL;
HUMAN;
HYPERTROPHIC PYLORUS STENOSIS;
LETTER;
PRIORITY JOURNAL;
SMOOTH MUSCLE;
VOMITING;
FEMALE;
FETUS DISEASE;
HYPERTROPHY;
METABOLISM;
METHODOLOGY;
NEWBORN;
NOTE;
PREGNANCY;
PRENATAL DEVELOPMENT;
PRENATAL DIAGNOSIS;
PYLORUS STENOSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
FEMALE;
FETAL DISEASES;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
HYPERTROPHY;
INFANT, NEWBORN;
MUSCLE, SMOOTH;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
PREGNANCY;
PRENATAL DIAGNOSIS;
PYLORIC STENOSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0035459239
PISSN: 00223468
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
